COGNITION THERAPEUTICS INCCGTXEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CGTX Q1 2024 Key Financial Metrics
Revenue
$-10.0K
Gross Profit
N/A
Operating Profit
$-14.1M
Net Profit
$-9.2M
Gross Margin
N/A
Operating Margin
141020.0%
Net Margin
91510.0%
YoY Growth
0.0%
EPS
$-0.27
COGNITION THERAPEUTICS INC Q1 2024 Financial Summary
COGNITION THERAPEUTICS INC reported revenue of $-10.0K for Q1 2024, with a net profit of $-9.2M (91510.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $-10.0K |
|---|---|
| Net Profit | $-9.2M |
| Gross Margin | N/A |
| Operating Margin | 141020.0% |
| Report Period | Q1 2024 |
COGNITION THERAPEUTICS INC Annual Revenue by Year
COGNITION THERAPEUTICS INC annual revenue history includes year-by-year totals (for example, 2023 revenue was $-27.0K).
| Year | Annual Revenue |
|---|---|
| 2023 | $-27.0K |
| 2022 | $-28.0K |
Income Statement
| Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $-7000 | $-2000 | $-10000 | $-10000 | $-6000 | $-2000 | $-9000 | $-10000 |
| YoY Growth | 98.0% | N/A | N/A | -11.1% | 14.3% | 0.0% | 10.0% | 0.0% |
Balance Sheet
| Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $52.8M | $53.6M | $50.4M | $45.7M | $44.0M | $38.8M | $35.2M | $38.9M |
| Liabilities | $8.9M | $14.2M | $10.2M | $9.9M | $9.6M | $9.8M | $10.7M | $10.0M |
| Equity | $43.9M | $39.3M | $40.2M | $35.8M | $34.4M | $28.9M | $24.5M | $28.9M |
Cash Flow
| Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-5.4M | $-4000 | $-10.2M | $-2.7M | $-3.7M | $-4.2M | $-5.5M | $-7.2M |